CDKN2A and adrenal cortex carcinoma: CDKN2A expression was significantly up-regulated in ACC, CESC, AML, DLBC, OV, PAAD, PCPG, sarcoma, THYM, and UCS, whereas significantly down-regulated in TGCT.